Arabino mycolates from synthetic mycolic acids

[1]  J. Piette,et al.  Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosis , 2016, Journal of Innate Immunity.

[2]  M. Baird,et al.  The synthesis of methoxy and keto mycolic acids containing methyl-trans-cyclopropanes , 2013 .

[3]  J. Grooten,et al.  Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis. , 2012, Progress in lipid research.

[4]  N. Kusunose,et al.  Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity. , 2011, Drug discoveries & therapeutics.

[5]  Gurdyal S Besra,et al.  Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host–pathogen interaction , 2011, FEMS microbiology reviews.

[6]  J. Grooten,et al.  Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern , 2011, European journal of immunology.

[7]  M. Beukes,et al.  Structure–function relationships of the antigenicity of mycolic acids in tuberculosis patients , 2010, Chemistry and physics of lipids.

[8]  R. Peeling,et al.  The TDR Tuberculosis Specimen Bank: a resource for diagnostic test developers. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  M. R. Richards,et al.  Probing the effect of acylation on arabinofuranose ring conformation in di- and trisaccharide fragments of mycobacterial arabinogalactan. , 2010, The Journal of organic chemistry.

[10]  D. Ronning,et al.  Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis , 2010, Medicinal research reviews.

[11]  N. Kusunose,et al.  Isolation and identification of arabinose mycolates of Cell Wall Skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105). , 2010, Journal of microbiological methods.

[12]  M. Baird,et al.  The synthesis of single enantiomers of mycobacterial ketomycolic acids containing cis-cyclopropanes , 2009 .

[13]  M. Daffé,et al.  Partial redundancy in the synthesis of the D-arabinose incorporated in the cell wall arabinan of Corynebacterineae. , 2008, Microbiology.

[14]  D. Ronning,et al.  Synthesis of methyl 5-S-alkyl-5-thio-D-arabinofuranosides and evaluation of their antimycobacterial activity. , 2008, Bioorganic & medicinal chemistry.

[15]  Yves L Janin,et al.  Antituberculosis drugs: ten years of research. , 2007, Bioorganic & medicinal chemistry.

[16]  M. Deysel,et al.  The first syntheses of single enantiomers of the major methoxymycolic acid of Mycobacterium tuberculosis , 2007 .

[17]  N. Kusunose,et al.  Synthesis and TNF-alpha inducing activities of mycoloyl-arabinan motif of mycobacterial cell wall components. , 2006, Bioorganic & medicinal chemistry.

[18]  M. Baird,et al.  The synthesis of a single enantiomer of a major α-mycolic acid of M. tuberculosis , 2005 .

[19]  Juan Xie,et al.  Regioselective debenzylation of C-glycosyl compounds by boron trichloride. , 2005, Carbohydrate research.

[20]  P. Brennan.  Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. , 2003, Tuberculosis.

[21]  Luiz Augusto Basso,et al.  Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. , 2002, Current pharmaceutical biotechnology.

[22]  Tsuyoshi Fujita,et al.  Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. , 2002, Microbiology.

[23]  A. Cuzzupe,et al.  Enantiospecific synthesis of the phospholipase A2 inhibitor (-)-cinatrin B. , 2002, The Journal of organic chemistry.

[24]  D. Minnikin,et al.  Separation and characterization of individual mycolic acids in representative mycobacteria. , 2001, Microbiology.

[25]  M. Rejžek,et al.  A Mild Approach to the Synthesis of sn‐Glycerol 1,2‐Di‐γ‐linolenate 3‐Palmitate , 2000 .

[26]  M. Baird,et al.  The synthesis of single enantiomers of a meromycolic acid , 2000 .

[27]  I. Mikhailopulo,et al.  A Novel Route for the Synthesis of Deoxy Fluoro Sugars and Nucleosides , 1999 .

[28]  N. Fujiwara,et al.  Anti‐Cord Factor (Trehalose 6,6′‐Dimycolate) IgG Antibody in Tuberculosis Patients Recognizes Mycolic Acid Subclasses , 1999, Microbiology and immunology.

[29]  R. Slayden,et al.  Mycolic acids: structure, biosynthesis and physiological functions. , 1998, Progress in lipid research.

[30]  G. Besra,et al.  A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. , 1995, Biochemistry.

[31]  P. Brennan,et al.  Major structural features of the cell wall arabinogalactans of Mycobacterium, Rhodococcus, and Nocardia spp. , 1993, Carbohydrate research.

[32]  I. Azuma,et al.  Regression of line-10 hepatocellular carcinomas following treatment with water-soluble, microbial extracts combined with trehalose or arabinose mycolates , 1978, Cancer Immunology, Immunotherapy.

[33]  I. Azuma,et al.  Further studies on the structural requirements of agents for immunotherapy of the guinea pig line-10 tumor , 1978, Cancer Immunology, Immunotherapy.

[34]  I. Azuma,et al.  Isolation and Characterization of Arabinose Mycolate from Firmly Bound Lipids of Mycobacteria , 1969, Journal of bacteriology.

[35]  I. Azuma,et al.  Fractionation of mycobacterial cell wall. Isolation of arabinose mycolate and arabinogalactan from cell wall fraction of Mycobacterium tuberculosis strain Aoyama B , 1968, Journal of bacteriology.

[36]  I. Azuma,et al.  Chemical and immunological properties of polysaccharides of wax D extracted from Mycobacterium tuberculosis strain Aoyama B , 1968, Journal of bacteriology.

[37]  I. Azuma,et al.  ISOLATION OF ARABINOSE MYCOLATE FROM WAX D FRACTION OF HUMAN TYPE TUBERCLE BACILLUS AOYAMA B STRAIN. , 1965, Journal of biochemistry.

[38]  I. Azuma,et al.  A TOXIC SUBSTANCE ISOLATED FROM FIRMLY BOUND LIPIDS OF MYCOBACTERIUM SMEGMATIS. , 1964, Journal of biochemistry.

[39]  I. Azuma,et al.  Studies on the firmly bound lipids of human tubercle bacillus , 1962, Journal of biochemistry.

[40]  E. Lederer,et al.  Structure of the Mycolic Acids of Mycobacteria , 1950, Nature.

[41]  R. J. Anderson.  Structural Peculiarities of Acid-fast Bacterial Lipids. , 1941 .

[42]  H. Nikaido,et al.  The envelope of mycobacteria. , 1995, Annual review of biochemistry.

[43]  Silva Cl.  Inflammation induced by mycolic acid-containing glycolipids of Mycobacterium bovis (BCG). , 1985 .